Detalhe da pesquisa
1.
Review of quality deficiencies found in active pharmaceutical ingredient master files submitted to the WHO Prequalification of Medicines Programme.
J Pharm Pharm Sci
; 17(2): 169-86, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24934546
2.
Essential medicines for universal health coverage.
Lancet
; 389(10067): 403-476, 2017 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-27832874
3.
Treating snake bites--a call for partnership.
Lancet
; 386(10010): 2252, 2015 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26681285
4.
Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting.
Clin Ther
; 42(8): 1595-1610.e5, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32782137
5.
Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet.
Expert Rev Clin Pharmacol
; 13(9): 925-934, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32990065
6.
CIOMS Guide To Vaccine Safety Communication - Executive summary.
Vaccine
; 37(3): 401-408, 2019 01 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30554796
7.
Quality of medicines in resource-limited settings: need for ethical guidance.
Glob Bioeth
; 29(1): 81-94, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30245610
8.
Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
PLoS One
; 13(5): e0197490, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29787579
9.
How the concept of WHO-listed authorities will change international procurement policies for medicines.
BMJ Glob Health
; 6(Suppl 3)2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35144982
10.
Drug manufacturing in Africa.
Lancet
; 376(9745): 958, 2010 Sep 18.
Artigo
Inglês
| MEDLINE | ID: mdl-20851259
11.
Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities.
J Public Health Policy
; 37(3): 315-333, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26961261
12.
The Work of the Council for International Organizations of Medical Sciences (CIOMS) in Global Pharmacovigilance.
Drug Saf
; 43(11): 1067-1071, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33034859
13.
Regulatory framework for access to safe, effective quality medicines.
Antivir Ther
; 19 Suppl 3: 69-77, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25310085
14.
Boosting access to essential medicines for children.
Lancet
; 368(9545): 1419, 2006 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-17055942
15.
Regulatory policy for research and development of vaccines for public health emergencies.
Expert Rev Vaccines
; 15(9): 1075-7, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27181597
16.
The biowaiver procedure: its application to antituberculosis products in the WHO prequalification programme.
J Pharm Sci
; 100(3): 822-30, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-20928870
17.
Ensuring ethical drug promotion--whose responsibility?
Lancet
; 362(9385): 747, 2003 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-12957107
18.
Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology.
Basic Clin Pharmacol Toxicol
; 107(1): 531-59, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20590536
19.
Promoting GMP implementation: developing training materials for the international audience.
Qual Assur
; 10(1): 11-27, 2003.
Artigo
Inglês
| MEDLINE | ID: mdl-12746156
20.
WHO perspective on preventing avoidable harm from medicines.
BMJ
; 332(7554): 1393-4, 2006 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-16763265